Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
MUNDELEIN, Ill., July 27 /PRNewswire/ -- Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced plans to debut its expanded cell image analysis portfolio during this year's American Association of Clinical Chemistry's (AACC) Annual Conference and Clinical Lab Expo July 25 - 29 in Anaheim, California. The CellaVision® DM1200 and DM96 systems for the mid-size to larger clinical laboratories and Medica's EasyCell® assistant for the smaller clinical laboratories will be exhibited at Sysmex's booth #4833.
The CellaVision® DM-Series locates, identifies, and pre-classifies blood cells by means of automatic microscopy and advanced image processing. Sysmex's most recent CellaVision addition to its hematology product offering is the CellaVision® DM1200. The DM1200 opens up new ways of handling manual differentials traditionally performed on a microscope by automatically performing a preliminary differential count on peripheral blood. The analyzer pre-classifies the white blood cells, pre-characterizes parts of the red morphology and provides functionality for platelet estimation. By automating the manual differential, laboratories can experience enhanced turnaround times without sacrificing quality. Its high degree of automation allows for an escalating workload without additional headcount. The CellaVision DM96 cell image analysis analyzer supports high-volume laboratories and has been a part of the Sysmex America hematology product offering since 2004.
The Medica EasyCell® assistant enables smaller clinical laboratories to achieve greater detection and examination of abnormal cells while providing more detailed imaging re